Firms can do much individually and even more collectively to prevent terminal sterilization capacity shortfalls from triggering parenteral drug shortages, a sterilization expert told the ISPE Aseptic Conference in March.
Emily Craven, Boston Scientific’s director, global sterility assurance, shared her advice on the eve of the Environmental Protection Agency’s...